Therefore, targeting CTGF may represent a promising strategy in cancer, particularly in ccRCC, where intratumoural fibrosis might lead to cancer aggressiveness and is related to poor prognostic parameters, including Fuhrman nuclear grade, intratumour necrosis, and lymphovascular invasion. This evidence concerns the gene CCN2 and nonpapillary renal cell carcinoma.